Positron (POSC) Stock Price, News & Analysis

Company Overview

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Key Stats

• Today's Range: $1.42 to $1.50
• 50-Day Range: $1.35 to $1.87
• 52-Week Range: $0.92 to $2.94
• Volume: 4,660 shs
• Average Volume: 18,171 shs
• Market Capitalization: $44.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Positron Stock Analysis - MarketRank™

Positron scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Positron.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Positron is -11.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Positron is -11.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of Positron have been sold short.

Short Interest Ratio / Days to Cover

Positron has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Positron has recently decreased by 92.31%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Positron does not currently pay a dividend.

Dividend Growth

Positron does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of Positron have been sold short.

Short Interest Ratio / Days to Cover

Positron has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Positron has recently decreased by 92.31%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.50

News Sentiment

Positron has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Positron this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Positron insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.20% of the stock of Positron is held by insiders. A high percentage of insider ownership can be a sign of company health.

POSC Stock Analysis - Frequently Asked Questions

How have POSC shares performed this year?

Positron's stock was trading at $1.01 at the beginning of the year. Since then, POSC stock has increased by 40.6% and is now trading at $1.42.

How were Positron's earnings last quarter?

Positron Corp. (OTCMKTS:POSC) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.05) earnings per share (EPS) for the quarter. The company earned $0.12 million during the quarter. Positron had a negative trailing twelve-month return on equity of 419.44% and a negative net margin of 592.35%.

How do I buy shares of Positron?

Shares of POSC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Positron own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Positron investors own include Rocket Lab (RKLB), Atlas Lithium (ATLX), Archer Aviation (ACHR), Camber Energy (CEI), OriginOil (OCLN), Baltic International USA (BISA) and

Company Calendar

• Last Earnings: 5/15/2025
• Today: 10/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:POSC
• CIK: N/A
• Web: www.positron.com
• Phone: (317) 576-0183
• Fax: 630-537-1249
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.39 million
• Net Margins: -592.35%
• Pretax Margin: -719.18%
• Return on Equity: -419.44%
• Return on Assets: -79.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.93
• Quick Ratio: 1.37

Sales & Book Value

• Annual Sales: $590 thousand
• Price / Sales: 75.60
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -35.50

Miscellaneous

• Outstanding Shares: 31,410,000
• Free Float: 26,003,000
• Market Cap: $44.60 million
• Optionable: Not Optionable
• Beta: 0.20